Benitec Biopharma Inc. BNTC
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 179.97M | 184.76M | 188.79M | 94.48M | 97.74M |
| Total Receivables | 4.00K | 3.00K | 130.00K | 7.00K | 33.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.60M | 1.14M | 562.00K | 480.00K | 628.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 114.00K | 114.00K | 113.00K | 113.00K | 113.00K |
| Total Current Assets | 181.69M | 186.02M | 189.60M | 95.08M | 98.52M |
|
|
|||||
| Total Current Assets | 181.69M | 186.02M | 189.60M | 95.08M | 98.52M |
| Net Property, Plant & Equipment | 871.00K | 916.00K | 1.02M | 873.00K | 991.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 67.00K | 67.00K | 66.00K | 75.00K | 83.00K |
| Total Assets | 182.62M | 187.00M | 190.68M | 96.03M | 99.59M |
|
|
|||||
| Total Accounts Payable | 913.00K | 635.00K | 1.02M | 271.00K | 201.00K |
| Total Accrued Expenses | 664.00K | 687.00K | 617.00K | 720.00K | 524.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 496.00K | 482.00K | 468.00K | 414.00K | 354.00K |
| Total Finance Division Other Current Liabilities | 3.27M | 1.47M | 700.00K | 620.00K | 723.00K |
| Total Other Current Liabilities | 3.27M | 1.47M | 700.00K | 620.00K | 723.00K |
| Total Current Liabilities | 5.34M | 3.27M | 2.80M | 2.03M | 1.80M |
|
|
|||||
| Total Current Liabilities | 5.34M | 3.27M | 2.80M | 2.03M | 1.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 266.00K | 394.00K | 519.00K | 403.00K | 495.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.61M | 3.67M | 3.32M | 2.43M | 2.30M |
|
|
|||||
| Common Stock & APIC | 451.70M | 445.20M | 437.22M | 331.49M | 326.31M |
| Retained Earnings | -273.72M | -260.91M | -248.98M | -237.14M | -228.18M |
| Treasury Stock & Other | -963.00K | -952.00K | -883.00K | -750.00K | -839.00K |
| Total Common Equity | 177.01M | 183.33M | 187.36M | 93.60M | 97.30M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 177.01M | 183.33M | 187.36M | 93.60M | 97.30M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 177.01M | 183.33M | 187.36M | 93.60M | 97.30M |
|
|
|||||